Hacked by islam_Bey imhatimi.org

Strides Arcolab Ltd has informed BSE about Press Release titled “Strides Arcolab receives 2 ANDA approvals for Ondansetron Injection USP, 2 mg/ml (20 ml vials) and 2 mg/ml (2 ml vials).

Press Release :

“Stride Arcolab today announced receipt of 2 ANDA approval for Ondansctron Injection USP, 2 mg/ml (20 ml vials) and 2 mg/ml (2 ml vials).

The product is licensed to Akorn-Strides, LLC, which is a Joint Venture that was formed in 2004 by Akorn, Inc and Stride Arcolab Ltd.

Mr. Arun Kumar ? Vice Chairman and Group CEO of Strides Arcolab stated:

“These approvals reflect yet another significant milestone for the Akorn-Strides partnership which now has approvals for five sterile inject able products and plans for commercialization are underway.”

Tags: Strides Arcolab

This entry was posted on Friday, April 25th, 2008 at 6:15 am and is filed under News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.